Search results
Results from the WOW.Com Content Network
Target ClearRx prescription bottles. ClearRx is a trademark for a design for prescription drug packaging, designed by design student Deborah Adler as a thesis project and adopted by Target Corporation (with refinements by industrial designer Klaus Rosburg) for use in their in-store pharmacies in 2005. [1]
Designer drugs are structural or functional analogues of controlled substances that are designed to mimic the pharmacological effects of the parent drug while avoiding detection or classification as illegal.
Birth control pills in blister packs. Formed solid unit doses of pharmaceuticals (capsules, suppositories, tablets, etc.) are commonly packed in blister packs. In Europe about 85% of solid unit doses are packed in blister packs with only about 20% in North America. [5] Blister packs are pre-formed plastic/paper/foil packaging used for formed ...
This is a list of free and open-source software (FOSS) packages, computer software licensed under free software licenses and open-source licenses.Software that fits the Free Software Definition may be more appropriately called free software; the GNU project in particular objects to their works being referred to as open-source. [1]
Other designer drugs were prepared for the first time in clandestine laboratories. [4] Because the efficacy and safety of these substances have not been thoroughly evaluated in animal and human trials, the use of some of these drugs may result in unexpected side effects. [5] The development of designer drugs may be considered a subfield of drug ...
2,5-Dimethoxy-4-methylamphetamine (DOM; known as STP, standing for "Serenity, Tranquility and Peace") is a psychedelic and a substituted amphetamine.It was first synthesized by Alexander Shulgin, and later reported in his book PiHKAL: A Chemical Love Story.
The phrase "drug design" is similar to ligand design (i.e., design of a molecule that will bind tightly to its target). [6] Although design techniques for prediction of binding affinity are reasonably successful, there are many other properties, such as bioavailability, metabolic half-life, and side effects, that first must be optimized before a ligand can become a safe and effictive drug.
U-47700, also known as U4, pink heroin, pinky, and pink, is an opioid analgesic drug developed by a team at Upjohn in the 1970s [1] which has around 7.5 times the potency of morphine in animal models.